128 related articles for article (PubMed ID: 27055430)
41. Case Report: Meningoencephalitis With Thrombotic Occlusive Vasculopathy in a Young EBV-Naïve Boy Is Associated With a Novel
Steininger J; Rossmanith R; Geier CB; Leiss-Piller A; Thonhauser L; Weiss S; Hainfellner JA; Freilinger M; Schmidt WM; Eibl MM; Wolf HM
Front Immunol; 2021; 12():747738. PubMed ID: 34987501
[TBL] [Abstract][Full Text] [Related]
42. No mutations of SAP/SH2D1A/DSHP and perforin genes in patients with Epstein-Barr virus-associated hemophagocytic syndrome in Japan.
Ma X; Okamura A; Yosioka M; Ishiguro N; Kikuta H; Kobayashi K
J Med Virol; 2001 Oct; 65(2):358-61. PubMed ID: 11536244
[TBL] [Abstract][Full Text] [Related]
43. Skin lesions in a boy with X-linked lymphoproliferative disorder: comparison of 5 SH2D1A deletion cases.
Mejstríková E; Janda A; Hrusák O; Bucková H; Vlcková M; Hancárová M; Freiberger T; Ravcuková B; Vesely K; Fajkusová L; Kopecková L; Sumerauer D; Kabícková E; Sedivá A; Stary J; Sedlácek Z
Pediatrics; 2012 Feb; 129(2):e523-8. PubMed ID: 22271700
[TBL] [Abstract][Full Text] [Related]
44. [Eperythrozoonosis complicated with hemophagocytic syndrome: report of four cases and review of literature].
Li JG; Zhang D; Zhou ZX; Li SN; Kang M; Lai JM
Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):303-307. PubMed ID: 29614573
[No Abstract] [Full Text] [Related]
45. [Case of X-linked lymphoproliferative syndrome (XLP) with multiple nodular lesions in the brain].
Tateishi T; Tanaka K; Ito Y; Mitsuo K
Rinsho Shinkeigaku; 2006 Apr; 46(4):254-60. PubMed ID: 16768091
[TBL] [Abstract][Full Text] [Related]
46. Treatment of the X-linked lymphoproliferative, Griscelli and Chédiak-Higashi syndromes by HLH directed therapy.
Trottestam H; Beutel K; Meeths M; Carlsen N; Heilmann C; Pasić S; Webb D; Hasle H; Henter JI
Pediatr Blood Cancer; 2009 Feb; 52(2):268-72. PubMed ID: 18937330
[TBL] [Abstract][Full Text] [Related]
47. Fatal EBV infection and variable clinical manifestations in an XLP-1 pedigree - rapid diagnosis of primary immunodeficiencies may save lives.
Sperl D; Benesch M; Urban C; Lackner H; Sovinz P; Speicher MR; Uhrig S; Schwarzbraun T; Schwinger W; zur Stadt U; Beutel K; Janka G; Scarpatetti M; Seidel MG
Klin Padiatr; 2012 Oct; 224(6):386-9. PubMed ID: 23143765
[TBL] [Abstract][Full Text] [Related]
48. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
[TBL] [Abstract][Full Text] [Related]
49. Study of SH2D1A gene mutation in paediatric patients with B-cell lymphoma.
Koochakzadeh L; Hosseinverdi S; Hedayat M; Farahani F; Tofighi A; Eghbali M; Bidoki AZ; Izadyar M; Rahiminejad MS; Ramyar A; Aghamohammadi A; Rezaei N
Allergol Immunopathol (Madr); 2015; 43(6):568-70. PubMed ID: 25982576
[TBL] [Abstract][Full Text] [Related]
50. Follicular lymphoma in a X-linked lymphoproliferative syndrome carrier female.
Woon ST; Ameratunga R; Croxson M; Taylor G; Neas K; Edkins E; Browett P; Gane E; Munn S
Scand J Immunol; 2008 Aug; 68(2):153-8. PubMed ID: 18702745
[TBL] [Abstract][Full Text] [Related]
51. Primary Immunodeficiencies Inducing EBV-Associated Severe Illnesses.
Miyawaki T
Iran J Allergy Asthma Immunol; 2004 Jun; 3(2):51-7. PubMed ID: 17301392
[TBL] [Abstract][Full Text] [Related]
52. Diagnosis of X-linked lymphoproliferative disease by analysis of SLAM-associated protein expression.
Gilmour KC; Cranston T; Jones A; Davies EG; Goldblatt D; Thrasher A; Kinnon C; Nichols KE; Gaspar HB
Eur J Immunol; 2000 Jun; 30(6):1691-7. PubMed ID: 10898506
[TBL] [Abstract][Full Text] [Related]
53. X-linked lymphoproliferative disease: a progressive immunodeficiency.
Morra M; Howie D; Grande MS; Sayos J; Wang N; Wu C; Engel P; Terhorst C
Annu Rev Immunol; 2001; 19():657-82. PubMed ID: 11244050
[TBL] [Abstract][Full Text] [Related]
54. Different Phenotypic Presentations of X-Linked Lymphoproliferative Disease in Siblings with Identical Mutations.
Nademi Z; Radwan N; Rao K; Gilmour K; Worth A; Booth C
J Clin Immunol; 2019 Jul; 39(5):523-526. PubMed ID: 31144249
[No Abstract] [Full Text] [Related]
55. Fatal hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection in a patient with a novel mutation in the signaling lymphocytic activation molecule-associated protein.
Halasa NB; Whitlock JA; McCurley TL; Smith JA; Zhu Q; Ochs H; Dermody TS; Crowe JE
Clin Infect Dis; 2003 Nov; 37(10):e136-41. PubMed ID: 14583885
[TBL] [Abstract][Full Text] [Related]
56. Langerhans cell histiocytosis complicated with hemophagocytic lymphohistiocytosis in a boy with a novel XIAP mutation: A case report.
Guo X; Li Q; Gao J
Medicine (Baltimore); 2018 Nov; 97(44):e13019. PubMed ID: 30383659
[TBL] [Abstract][Full Text] [Related]
57. Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Zhizhuo H; Junmei X; Yuelin S; Qiang Q; Chunyan L; Zhengde X; Kunling S
Pediatr Blood Cancer; 2012 Mar; 58(3):410-4. PubMed ID: 21674762
[TBL] [Abstract][Full Text] [Related]
58. Clinical and molecular characteristics of Chinese patients with X-linked lymphoproliferative syndrome type 1.
An YF; Luo XB; Yang X; Wang J; Li L; Zhao XD
Pediatr Blood Cancer; 2014 Nov; 61(11):2043-7. PubMed ID: 25044636
[TBL] [Abstract][Full Text] [Related]
59. X-linked inhibitor of apoptosis (XIAP) deficiency: the spectrum of presenting manifestations beyond hemophagocytic lymphohistiocytosis.
Speckmann C; Lehmberg K; Albert MH; Damgaard RB; Fritsch M; Gyrd-Hansen M; Rensing-Ehl A; Vraetz T; Grimbacher B; Salzer U; Fuchs I; Ufheil H; Belohradsky BH; Hassan A; Cale CM; Elawad M; Strahm B; Schibli S; Lauten M; Kohl M; Meerpohl JJ; Rodeck B; Kolb R; Eberl W; Soerensen J; von Bernuth H; Lorenz M; Schwarz K; Zur Stadt U; Ehl S
Clin Immunol; 2013 Oct; 149(1):133-41. PubMed ID: 23973892
[TBL] [Abstract][Full Text] [Related]
60. Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis.
Kanegane H; Yang X; Zhao M; Yamato K; Inoue M; Hamamoto K; Kobayashi C; Hosono A; Ito Y; Nakazawa Y; Terui K; Kogawa K; Ishii E; Sumazaki R; Miyawaki T
Pediatr Allergy Immunol; 2012 Aug; 23(5):488-93. PubMed ID: 22433061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
